Cargando…
Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
BACKGROUND: Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR-TB) are poor. However, data about the type, frequency and severity of presumed drug-associated adverse events (AEs) and their association with treatment-related outcomes in patients with XDR-TB are s...
Autores principales: | Shean, Karen, Streicher, Elizabeth, Pieterson, Elize, Symons, Greg, van Zyl Smit, Richard, Theron, Grant, Lehloenya, Rannakoe, Padanilam, Xavier, Wilcox, Paul, Victor, Tommie C., van Helden, Paul, Groubusch, Martin, Warren, Robin, Badri, Motasim, Dheda, Keertan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646906/ https://www.ncbi.nlm.nih.gov/pubmed/23667572 http://dx.doi.org/10.1371/journal.pone.0063057 |
Ejemplares similares
-
Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
por: Shean, Karen, et al.
Publicado: (2013) -
What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013) -
The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates
por: Tomasicchio, Michele, et al.
Publicado: (2016) -
High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis
por: Pietersen, Elize, et al.
Publicado: (2015) -
Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients
por: Lehloenya, Rannakoe J., et al.
Publicado: (2016)